Megatron, Harvard team on medical marijuana research

Former Detroit Lions wide receiver Calvin Johnson and ex-NFL lineman Rob Sims are teaming their marijuana company with Harvard University to research the benefits of medical marijuana to treat chronic traumatic encephalopathy, more commonly known as CTE, and pain management.Johnson and Sims established their marijuana business under the name Primitive and said Thursday at the Cannabis Capital Conference in Detroit that they’re hoping for a long-term relationship with Harvard that leads to paths of healing for NFL brethren and everyday Joes.Primitive participated in Harvard’s Global Catalyst Health Summit in May and committed to give research money and start a consortium with the brain-performance company NESTRE and Dr. Wilfred Ngwa. NESTRE does brain training with NFL athletes, including former quarterback and current ESPN analyst Josh McCown.Harvard will provide medical research for Primitive, run clinical trials tied to CTE and pain management all with support from Harvard Medical School.The medical school will provide support and quality assurance for any co-produced products.Because CTE is only currently diagnosed postmortem, Johnson and Sims are hopeful Harvard’s medical group can make advancement toward living diagnoses with Primitive assisting in treatment plans.